NeoLight is a medical device company developing empathy-driven and best-in-class technology for treating conditions in newborn infants. The Skylife™ phototherapy system, incorporating their flagship technology, received 510(k) clearance from the FDA in 2017 and is poised to disrupt the newborn care market. Neonatal jaundice is a condition that occurs in 6 out of 10 infants globally and is reported to be the single largest cause for hospital readmissions in neonates, according to the US Department of Health & Human Services.
NeoLight is based in Scottsdale, Arizona and is backed by several industry leaders including Dignity Health and Steve Case.
Brands: Skylife™ Phototherapy System